Suggested new mechanisms of antimalarial action for DDS involving inhibition of glucose utilization by the intraerythrocytic parasite.
D062365:Aminobenzoates / Q000494:pharmacology; D000818:Animals; D001322:Autoanalysis; D001692:Biological Transport / Q000187:drug effects; D002462:Cell Membrane; D003622:Dapsone / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D005492:Folic Acid / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D008288:Malaria / Q000188:drug therapy; D010961:Plasmodium / Q000187:drug effects* / Q000378:metabolism; D051381:Rats
D062365:Aminobenzoates; D003622:Dapsone; D005492:Folic Acid; D005947:Glucose